London
· Delayed Price · Currency is GBP · Price in GBXOptiBiotix Health Statistics
Total Valuation
OptiBiotix Health has a market cap or net worth of GBP 12.24 million. The enterprise value is 10.98 million.
| Market Cap | 12.24M |
| Enterprise Value | 10.98M |
Important Dates
The next estimated earnings date is Friday, December 27, 2024.
| Earnings Date | Dec 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
OptiBiotix Health has 97.94 million shares outstanding. The number of shares has increased by 5.52% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 97.94M |
| Shares Change (YoY) | +5.52% |
| Shares Change (QoQ) | +2.56% |
| Owned by Insiders (%) | 11.27% |
| Owned by Institutions (%) | 4.81% |
| Float | 86.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.49 |
| PB Ratio | 1.66 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.68 |
| EV / Sales | 19.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.18
| Current Ratio | 6.18 |
| Quick Ratio | 5.36 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -36.34% and return on invested capital (ROIC) is -15.23%.
| Return on Equity (ROE) | -36.34% |
| Return on Assets (ROA) | -13.93% |
| Return on Capital (ROIC) | -15.23% |
| Revenue Per Employee | 56,900 |
| Profits Per Employee | -298,400 |
| Employee Count | 10 |
| Asset Turnover | 0.06 |
| Inventory Turnover | 1.35 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.45% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -55.45% |
| 50-Day Moving Average | 13.77 |
| 200-Day Moving Average | 19.20 |
| Relative Strength Index (RSI) | 45.66 |
| Average Volume (20 Days) | 329,801 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OptiBiotix Health had revenue of GBP 569,000 and -2.98 million in losses. Loss per share was -0.03.
| Revenue | 569,000 |
| Gross Profit | 273,000 |
| Operating Income | -2.00M |
| Pretax Income | -2.99M |
| Net Income | -2.98M |
| EBITDA | -1.78M |
| EBIT | -2.00M |
| Loss Per Share | -0.03 |
Balance Sheet
| Cash & Cash Equivalents | 1.26M |
| Total Debt | n/a |
| Net Cash | 1.26M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 7.37M |
| Book Value Per Share | 0.08 |
| Working Capital | 1.62M |
Cash Flow
| Operating Cash Flow | -1.69M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 47.98% |
| Operating Margin | -351.67% |
| Pretax Margin | -525.13% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OptiBiotix Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.52% |
| Shareholder Yield | -5.52% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OptiBiotix Health has an Altman Z-Score of 19.04.
| Altman Z-Score | 19.04 |
| Piotroski F-Score | n/a |